Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute is a clinical research site located in Los Angeles, California, United States 90048.
Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.
Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute has participated in 35 clinical trials with 9 currently active.
Therapeutic areas: HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Triple Negative Breast Neoplasms.
Sponsors: Seagen Inc., Seagen, a wholly owned subsidiary of Pfizer, Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Los Angeles
Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute has 35 clinical trials on record, with 9 currently active. Their work covers HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Triple Negative Breast Neoplasms.
Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.